fluoxetine has been researched along with benzofurans in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (26.67) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McRae-Degueurce, A; Pujol, JF | 1 |
Buckholtz, NS; Sparks, DL | 1 |
Jobe, PC; Ray, TB | 1 |
Holmgren, B; Urbá-Holmgren, R | 1 |
Bartoszyk, GD; Hegenbart, R; Ziegler, H | 1 |
Cryan, JF; Dalvi, A; Lucki, I; Manning, DR; Page, ME; Saucy, B; Sullivan, A | 1 |
Knoll, J; Miklya, I | 1 |
Atmaca, S; Baktr, G; Cetin, SM; Ersoy, L; Ertürk, S | 1 |
Bartoszyk, GD; Hagan, JJ; Kew, JN; Roberts, C | 1 |
Cano, E; Fraiz, N; Orallo, F; Yáñez, M | 1 |
Platt, DM; Rowlett, JK; Rüedi-Bettschen, D; Spealman, RD | 1 |
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
Seyfried, CA; van Amsterdam, C | 1 |
Aguilar-Valles, A; Cao, R; Comai, S; De Gregorio, D; Eslamizade, MJ; Gobbi, G; Haji, N; Lacaille, JC; Luheshi, G; Matta-Camacho, E; Mechawar, N; Nadon, R; Nuñez, N; Popic, J; Rummel, C; Sharma, V; Sonenberg, N; Tanti, A; Turecki, G; Wiebe, S | 1 |
Achten, E; Cambron, M; Debruyne, J; Laureys, G; Reynders, T; Reyngoudt, H; Ribbens, A | 1 |
1 review(s) available for fluoxetine and benzofurans
Article | Year |
---|---|
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
1 trial(s) available for fluoxetine and benzofurans
Article | Year |
---|---|
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI,
Topics: Adult; Benzofurans; Brain; Double-Blind Method; Female; Fluoxetine; Gray Matter; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Organ Size; Phosphocreatine; Phosphorus Isotopes; Protons; Treatment Outcome; White Matter | 2018 |
13 other study(ies) available for fluoxetine and benzofurans
Article | Year |
---|---|
Correlation between the increase in tyrosine hydroxylase activity and the decrease in serotonin content in the rat locus coeruleus after 5,6-dihydroxytryptamine.
Topics: 5,6-Dihydroxytryptamine; Animals; Benzofurans; Fluoxetine; Locus Coeruleus; Male; Nerve Endings; Propylamines; Rats; Serotonin; Serotonin Antagonists; Tyrosine 3-Monooxygenase | 1979 |
Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Animals; Benzofurans; Carbolines; Citalopram; Clomipramine; Clorgyline; Fluoxetine; Harmine; Indoles; Methoxydimethyltryptamines; Mice; Mice, Inbred DBA; N,N-Dimethyltryptamine; Pargyline; Propylamines; Quipazine; Seizures; Selegiline | 1980 |
Effects of norepinephrine and 5-hydroxytryptamine reuptake inhibitors on electrically-induced spinal cord seizures in rats.
Topics: Animals; Benzofurans; Citalopram; Desipramine; Electric Stimulation; Female; Fluoxetine; Norepinephrine; Propylamines; Rats; Seizures; Serotonin Antagonists; Spinal Cord | 1980 |
Interaction of cholinergic and dopaminergic influences on yawning behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone | 1980 |
EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties.
Topics: Animals; Behavior, Animal; Benzofurans; Body Temperature; Fluoxetine; Indoles; Male; Piperazines; Presynaptic Terminals; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Vilazodone Hydrochloride | 1997 |
Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Benzofurans; Brain Chemistry; Cell Line; Extracellular Space; Female; Fluoxetine; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Indoles; Microdialysis; Piperazines; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Swimming; Vilazodone Hydrochloride | 2002 |
Analysis of the effect of (-)-BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Topics: Adrenergic Uptake Inhibitors; Animals; Benzofurans; Brain Chemistry; Brain Stem; Catecholamines; Clorgyline; Desipramine; Dopamine; Fluoxetine; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission | 2003 |
A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection.
Topics: Administration, Oral; Area Under Curve; Benzofurans; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Fluoxetine; Fluvoxamine; Half-Life; Hexanes; Humans; Kinetics; Reference Standards; Sensitivity and Specificity | 2005 |
Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleus.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzofurans; Dose-Response Relationship, Drug; Fluoxetine; Guinea Pigs; In Vitro Techniques; Indoles; Male; Piperazines; Pyridines; Raphe Nuclei; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vilazodone Hydrochloride | 2005 |
(-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Topics: Animals; Benzofurans; Blood Platelets; Brain; Cell Line; Citalopram; Clorgyline; Dose-Response Relationship, Drug; Fluoxetine; Humans; Imipramine; Iproniazid; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Selegiline; Serotonin; Stilbenes; Synaptosomes; Tritium; Wine | 2006 |
Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms.
Topics: Animals; Benzofurans; Citalopram; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Fluoxetine; Ligands; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa; Saimiri; Selective Serotonin Reuptake Inhibitors; Self Administration; Serotonin; Serotonin 5-HT1 Receptor Agonists | 2010 |
Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Benzofurans; Brain; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluoxetine; Indoles; Male; Paroxetine; Piperazines; Pyridines; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Vilazodone Hydrochloride | 2014 |
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzofurans; Citalopram; Depression; Depressive Disorder, Major; Eukaryotic Initiation Factor-4E; Female; Fluoxetine; Inflammation; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Serotonin and Noradrenaline Reuptake Inhibitors; Synaptic Transmission; Tumor Necrosis Factor-alpha | 2018 |